Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5198772
Max Phase: Preclinical
Molecular Formula: C17H14BrCl2N3
Molecular Weight: 411.13
Associated Items:
ID: ALA5198772
Max Phase: Preclinical
Molecular Formula: C17H14BrCl2N3
Molecular Weight: 411.13
Associated Items:
Canonical SMILES: C[C@H](c1c(Cl)ccc(C2CC2)c1Cl)n1cnc2cnc(Br)cc21
Standard InChI: InChI=1S/C17H14BrCl2N3/c1-9(23-8-22-13-7-21-15(18)6-14(13)23)16-12(19)5-4-11(17(16)20)10-2-3-10/h4-10H,2-3H2,1H3/t9-/m1/s1
Standard InChI Key: VGBVZMMGEFPKJB-SECBINFHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 411.13 | Molecular Weight (Monoisotopic): 408.9748 | AlogP: 5.99 | #Rotatable Bonds: 3 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 2.62 | CX LogP: 5.37 | CX LogD: 5.37 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.50 | Np Likeness Score: -0.71 |
1. Willard FS, Wainscott DB, Showalter AD, Stutsman C, Ma W, Cardona GR, Zink RW, Corkins CM, Chen Q, Yumibe N, Agejas J, Cumming GR, Minguez JM, Jiménez A, Mateo AI, Castaño AM, Briere DA, Sloop KW, Bueno AB.. (2021) Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor., 64 (6.0): [PMID:33721487] [10.1021/acs.jmedchem.1c00029] |
Source(1):